Cipla Limited

Sensex Falls 600 Pts From Day’s High, Nifty Below 23,400 — What Triggered the Sudden Market Reversal?

The market looked strong in the morning. But by noon, the mood had changed.The headline indices — Sensex falls 600 pts from day’s high, Nifty below 23,400 — tell the story. What started as a recovery attempt quickly turned into profit booking, caution, and volatility.Let’s break it down in a simp...

Pharmaceutical industry in India Q3 FY26 Results: India Formulations Shine as US Pricing Remains a Drag

Q3 FY26 Performance SnapshotThe Indian pharma sector delivered a steady Q3 FY26, with performance largely driven by domestic strength.Sales Growth: +13% YoYOperating Profit: +12% YoYPAT Growth: +1% YoYWhile revenue and operating profit expanded in tandem, net profit growth remained muted due to m...

Sensex and Nifty News: Indian Stock Market Slumps Over 1,000 Points Amid AI Concerns | Stock Market Today

The Indian stock market faced a sharp selloff on Friday, February 13, with global uncertainties and AI-related concerns triggering panic across sectors. The Sensex plunged 1,048 points, closing at 82,626.76, while the Nifty 50 fell 336 points to 25,471.10, breaching key psychological levels.Marke...

LIC Portfolio Rejig: BPCL, Adani Ports, Bank of Baroda — Top Stocks Sold and Bought in Q3FY26 | Stock Market Today

India’s largest domestic institutional investor, Life Insurance Corporation of India (LIC), has completed a significant portfolio rejig in the quarter ended December 2025. The insurer actively adjusted its holdings, trimming stakes in some companies while increasing exposure in others. These move...

Cipla Q3 Results: Net Profit Drops 57% as Manufacturing Halt and One-Time Costs Bite

Cipla’s Q3 performance tells a clear story—steady revenue, but pressure on profits.The pharma major reported a sharp year-on-year fall in net profit for the December quarter, weighed down by operational disruptions and one-time costs.While some parts of the business stayed resilient, a key manufa...

Sensex and Nifty News: IT Stocks Lead Market Rally as Benchmarks Snap Two-Day Losing Streak

Market Performance: Sensex and Nifty Bounce BackThe Indian stock market saw a notable recovery on Friday, January 16, with frontline indices snapping a two-day losing streak. Investor sentiment was bolstered by strong performances in IT and banking sectors, helping the benchmarks inch higher.Sens...

Sensex and Nifty News Today: Markets Slip for Third Straight Day, Broader Indices Hold Ground

Market PerformanceThe Sensex and Nifty news flow stayed cautious as Indian stock markets closed lower for the third consecutive session on Wednesday, January 7. The mood was restrained from the opening bell, and that tone stayed till the close.Sensex slipped 102 points, down 0.12%, ending the day...

Cipla Share Price Falls 3% After Eli Lilly Deal — Market Reacts to Weight-Loss Drug Launch in India

Market PerformanceOn October 24, Cipla’s share price slipped nearly 3%, even as the company revealed a major partnership with US-based pharma leader Eli Lilly. The fall comes just a day after Cipla touched its 52-week high of ₹1,673, extending its recent eight-session rally of over 7%.By mid-day,...

Pharma Stocks Plunge: Sun Pharma, Aurobindo, Cipla, Lupin Fall as Trump Cracks Down on Global Drug Prices

Market PerformancePharma stocks witnessed a sharp sell-off on Friday, triggered by new developments from the United States that rattled investor sentiment.The Nifty Pharma index fell over 2.8%, marking its third consecutive day of decline.Sun Pharma led the fall with a 4% drop, becoming the worst...

Pharma Stocks Stay Flat as Trump Reignites Tariff Threats

Market PerformancePharma stocks traded flat in early trade on Wednesday, July 16, as U.S. President Donald Trump once again raised concerns over potential import tariffs on pharmaceutical products.At 9:20 a.m., the Nifty Pharma index was essentially unchanged, reflecting investor caution amid glo...

Pharma Stocks Slide: Aurobindo Pharma, Lupin, Dr Reddy’s, and Others See Sharp Decline Amid Tariff Concerns

Market PerformanceOn July 8, Indian pharmaceutical stocks experienced a notable dip in early trade as global trade tensions escalated. The Nifty Pharma index slipped nearly 1%, hovering around 22,159 during morning hours.This marked the second straight day of losses for the index, after an extend...

Pharma Stocks Buck Market Trend as Nifty Pharma Emerges Sole Gainer; Ajanta Pharma, Ipca Labs Lead Surge

Market PerformanceDespite a weak broader market on June 12, Nifty Pharma outshone as the only sectoral gainer, climbing nearly 1% to 22,243 in morning trade.This uptrend in pharma shares was primarily driven by easing global trade concerns after U.S. President Donald Trump's announcement regardin...

Sensex, Nifty Post Strong Gains Ahead of RBI Policy Decision

Market PerformanceOn April 8, Indian stock markets rebounded sharply, ending a three-day losing streak. The Sensex rose by 1,089.18 points, or 1.49%, closing at 74,227.08. The Nifty also saw a strong recovery, climbing 374.25 points, or 1.69%, to finish at 22,535.85. This rise followed a signific...

Indian Markets Close FY25 Lower Amid Trade Tensions

Market PerformanceIndian stock markets ended the final trading session of FY25 negatively, influenced by concerns surrounding upcoming U.S. tariffs and economic data. The Nifty 50 index fell by 0.31% to 23,519 points, while the Sensex declined 0.25%, closing at 77,414 points.Broader market indice...